• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

Pathologic diagnosis of advanced lung cancer based on small biopsies and cytology: a paradigm shift.

作者信息

Travis William D, Rekhtman Natasha, Riley Gregory J, Geisinger Kim R, Asamura Hisao, Brambilla Elisabeth, Garg Kavita, Hirsch Fred R, Noguchi Masayuki, Powell Charles A, Rusch Valerie W, Scagliotti Giorgio, Yatabe Yasushi

出版信息

J Thorac Oncol. 2010 Apr;5(4):411-4. doi: 10.1097/JTO.0b013e3181d57f6e.

DOI:10.1097/JTO.0b013e3181d57f6e
PMID:20357614
Abstract
摘要

相似文献

1
Pathologic diagnosis of advanced lung cancer based on small biopsies and cytology: a paradigm shift.基于小活检和细胞学检查的晚期肺癌病理诊断：范式转变
J Thorac Oncol. 2010 Apr;5(4):411-4. doi: 10.1097/JTO.0b013e3181d57f6e.
2
Nonsmall cell lung carcinoma: diagnostic difficulties in small biopsies and cytological specimens: Number 2 in the Series "Pathology for the clinician" Edited by Peter Dorfmüller and Alberto Cavazza.非小细胞肺癌：小活检和细胞学标本的诊断难点：“临床医生病理学”系列第2号，由彼得·多夫米勒和阿尔贝托·卡瓦扎编辑。
Eur Respir Rev. 2017 Jun 28;26(144). doi: 10.1183/16000617.0007-2017. Print 2017 Jun 30.
3
Subtyping of non-small cell lung carcinoma: a comparison of small biopsy and cytology specimens.非小细胞肺癌的亚型分类：小活检和细胞学标本的比较。
J Thorac Oncol. 2011 Nov;6(11):1849-56. doi: 10.1097/JTO.0b013e318227142d.
4
Lung cancer and molecular testing in small biopsies versus cytology: The Logics of Worlds.肺癌与小活检标本的分子检测对细胞病理学的挑战：世界的逻辑。
Cancer Cytopathol. 2020 Sep;128(9):637-641. doi: 10.1002/cncy.22291.
5
PD-L1 expression in non-small cell lung carcinoma: Comparison among cytology, small biopsy, and surgical resection specimens.非小细胞肺癌中程序性死亡受体配体1（PD-L1）的表达：细胞学、小活检及手术切除标本的比较
Cancer Cytopathol. 2017 Dec;125(12):896-907. doi: 10.1002/cncy.21937. Epub 2017 Oct 12.
6
Programmed death-ligand 1 immunoexpression in matched biopsy and liquid-based cytology samples of advanced stage non-small cell lung carcinomas.晚期非小细胞肺癌配对活检和液基细胞学样本中程序性死亡配体1的免疫表达情况
Cytopathology. 2018 Dec;29(6):550-557. doi: 10.1111/cyt.12605. Epub 2018 Jul 30.
7
Nuclear grade based on transbronchial cytology is an independent prognostic factor in patients with advanced, unresectable non-small cell lung cancer.基于经支气管细胞学检查的核分级是晚期不可切除非小细胞肺癌患者的独立预后因素。
Cancer Cytopathol. 2016 Sep;124(9):630-40. doi: 10.1002/cncy.21736. Epub 2016 May 13.
8
Lung cancer biopsy: Can diagnosis be changed after immunohistochemistry when the H&E-Based morphology corresponds to a specific tumor subtype?肺癌活检：当基于苏木精-伊红染色的形态学符合特定肿瘤亚型时，免疫组化后诊断会改变吗？
Clinics (Sao Paulo). 2018 Oct 29;73:e361. doi: 10.6061/clinics/2018/e361.
9
EGFR analysis on scrapings from cytology smears in lung carcinoma, an effective alternative to testing on trucut biopsies.在肺癌细胞学涂片的刮片中进行 EGFR 分析，是替代 tru-cut 活检的有效方法。
Diagn Cytopathol. 2021 Oct;49(10):1155-1163. doi: 10.1002/dc.24856. Epub 2021 Aug 25.
10
The value of cytology in the diagnostics of lung cancer.细胞学在肺癌诊断中的价值。
APMIS. 2005 Mar;113(3):208-12. doi: 10.1111/j.1600-0463.2005.apm1130309.x.

引用本文的文献

1
Synergizing Success: The Role of Anlotinib Combinations in Advanced Non-Small Cell Lung Cancer Treatment.协同铸就成功：安罗替尼联合用药在晚期非小细胞肺癌治疗中的作用
Pharmaceuticals (Basel). 2025 Apr 16;18(4):585. doi: 10.3390/ph18040585.
2
The rapidly changing field of predictive biomarkers of non-small cell lung cancer.不断变化的非小细胞肺癌预测生物标志物领域。
Pathol Oncol Res. 2024 Jun 17;30:1611733. doi: 10.3389/pore.2024.1611733. eCollection 2024.
3
PET/CT-based deep learning grading signature to optimize surgical decisions for clinical stage I invasive lung adenocarcinoma and biologic basis under its prediction: a multicenter study.
基于 PET/CT 的深度学习分级特征，优化临床 I 期浸润性肺腺癌的手术决策及其预测的生物学基础：一项多中心研究。
Eur J Nucl Med Mol Imaging. 2024 Jan;51(2):521-534. doi: 10.1007/s00259-023-06434-7. Epub 2023 Sep 19.
4
Lung adenocarcinoma and squamous cell carcinoma difficult for immunohistochemical diagnosis can be distinguished by lipid profile.肺腺癌和鳞状细胞癌的免疫组织化学诊断困难，可以通过脂质谱加以区分。
Sci Rep. 2023 Jul 26;13(1):12092. doi: 10.1038/s41598-023-37848-w.
5
Non-small cell lung cancer (NSCLC): A review of risk factors, diagnosis, and treatment.非小细胞肺癌（NSCLC）：风险因素、诊断和治疗的综述。
Medicine (Baltimore). 2023 Feb 22;102(8):e32899. doi: 10.1097/MD.0000000000032899.
6
[A Case of Advanced Lung Squamous Cell Carcinoma with CLIP1-ALK Fusion Gene].[1例伴有CLIP1-ALK融合基因的晚期肺鳞状细胞癌病例]
Zhongguo Fei Ai Za Zhi. 2022 Sep 20;25(9):696-700. doi: 10.3779/j.issn.1009-3419.2022.102.29.
7
A randomized phase II study of docetaxel or pemetrexed with or without the continuation of gefitinib after disease progression in elderly patients with non-small cell lung cancer harboring EGFR mutations (JMTO LC12-01).一项在非小细胞肺癌伴有 EGFR 突变的老年患者中进行的吉非替尼维持治疗的多西他赛或培美曲塞与不含吉非替尼的随机 II 期研究（JMTO LC12-01）。
Thorac Cancer. 2022 Jun;13(12):1827-1836. doi: 10.1111/1759-7714.14465. Epub 2022 May 13.
8
Impact of rapid on-site evaluation combined with endobronchial ultrasound and virtual bronchoscopic navigation in diagnosing peripheral lung lesions.快速现场评估联合支气管内超声及虚拟支气管镜导航在诊断周围型肺病变中的作用
BMC Pulm Med. 2022 Mar 31;22(1):117. doi: 10.1186/s12890-022-01917-z.
9
Lung adenocarcinoma and lung squamous cell carcinoma cancer classification, biomarker identification, and gene expression analysis using overlapping feature selection methods.肺腺癌和肺鳞状细胞癌的癌症分类、生物标志物鉴定以及使用重叠特征选择方法的基因表达分析。
Sci Rep. 2021 Jun 25;11(1):13323. doi: 10.1038/s41598-021-92725-8.
10
The Diagnostic and Prognostic Roles of Combined Expression of Novel Biomarkers in Lung Adenocarcinoma and Lung Squamous Cell Carcinoma: An Immunohistochemical Study.新型生物标志物联合表达在肺腺癌和肺鳞癌中的诊断及预后作用：一项免疫组织化学研究
Iran J Pathol. 2021 Spring;16(2):162-173. doi: 10.30699/IJP.2020.130944.2452. Epub 2020 Dec 21.